| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nose Neoplasms | 4 | 2006 | 244 | 0.910 |
Why?
|
| Central Nervous System Infections | 4 | 2014 | 48 | 0.900 |
Why?
|
| Ependymoma | 2 | 2017 | 324 | 0.660 |
Why?
|
| Magnetic Resonance Imaging | 29 | 2019 | 34151 | 0.530 |
Why?
|
| Intelligence | 1 | 2019 | 895 | 0.530 |
Why?
|
| Myelitis | 1 | 2014 | 51 | 0.510 |
Why?
|
| Encephalitis | 1 | 2014 | 446 | 0.400 |
Why?
|
| Carotid Artery, Internal | 2 | 2003 | 473 | 0.380 |
Why?
|
| Tomography, X-Ray Computed | 26 | 2019 | 20308 | 0.370 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2011 | 573 | 0.370 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2017 | 865 | 0.360 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 1661 | 0.340 |
Why?
|
| Cerebral Hemorrhage | 1 | 2019 | 2518 | 0.340 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2006 | 235 | 0.320 |
Why?
|
| Frontal Sinus | 2 | 2004 | 50 | 0.320 |
Why?
|
| Cysts | 3 | 2018 | 630 | 0.320 |
Why?
|
| Radiology | 2 | 2019 | 1931 | 0.320 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2007 | 133 | 0.310 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2006 | 82 | 0.290 |
Why?
|
| Spinal Cord | 1 | 2014 | 1831 | 0.280 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 59 | 0.280 |
Why?
|
| Hemangiopericytoma | 1 | 2005 | 78 | 0.270 |
Why?
|
| Solvents | 1 | 2005 | 293 | 0.260 |
Why?
|
| Odontogenic Cysts | 1 | 2004 | 43 | 0.260 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2004 | 47 | 0.250 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2004 | 43 | 0.250 |
Why?
|
| Meningioma | 2 | 2020 | 1203 | 0.250 |
Why?
|
| Bell Palsy | 1 | 2003 | 43 | 0.240 |
Why?
|
| Hallucinogens | 1 | 2005 | 132 | 0.240 |
Why?
|
| Parotid Diseases | 1 | 2003 | 45 | 0.240 |
Why?
|
| Mandibular Neoplasms | 1 | 2004 | 133 | 0.240 |
Why?
|
| Tympanic Membrane | 1 | 2004 | 220 | 0.240 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2003 | 141 | 0.230 |
Why?
|
| Pharynx | 1 | 2005 | 419 | 0.230 |
Why?
|
| Appetite | 2 | 2014 | 233 | 0.220 |
Why?
|
| Oropharynx | 1 | 2002 | 131 | 0.220 |
Why?
|
| Plasmacytoma | 1 | 2002 | 184 | 0.220 |
Why?
|
| Neck | 1 | 2006 | 698 | 0.220 |
Why?
|
| Brain | 12 | 2019 | 24969 | 0.220 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 454 | 0.220 |
Why?
|
| Marijuana Abuse | 1 | 2005 | 389 | 0.210 |
Why?
|
| Facial Nerve | 1 | 2003 | 275 | 0.210 |
Why?
|
| Tinnitus | 1 | 2003 | 160 | 0.210 |
Why?
|
| Ear, Middle | 1 | 2003 | 325 | 0.200 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 532 | 0.200 |
Why?
|
| Nasal Polyps | 1 | 2005 | 320 | 0.200 |
Why?
|
| Neurofibromatosis 1 | 1 | 2005 | 524 | 0.200 |
Why?
|
| Carotid Arteries | 1 | 2005 | 977 | 0.200 |
Why?
|
| Meningeal Neoplasms | 2 | 2020 | 1221 | 0.200 |
Why?
|
| Calcinosis | 2 | 2013 | 1435 | 0.190 |
Why?
|
| Neuroradiography | 1 | 2019 | 71 | 0.190 |
Why?
|
| Spinal Diseases | 1 | 2005 | 557 | 0.190 |
Why?
|
| Cauda Equina | 1 | 2019 | 48 | 0.190 |
Why?
|
| Chondroma | 1 | 2018 | 60 | 0.180 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2020 | 153 | 0.170 |
Why?
|
| Granular Cell Tumor | 1 | 2018 | 52 | 0.170 |
Why?
|
| Foreign Bodies | 1 | 2002 | 396 | 0.170 |
Why?
|
| Hemangioma | 1 | 2003 | 741 | 0.170 |
Why?
|
| Spinal Cord Compression | 1 | 2019 | 223 | 0.160 |
Why?
|
| Deglutition Disorders | 1 | 2002 | 566 | 0.160 |
Why?
|
| Mycoses | 2 | 2014 | 368 | 0.160 |
Why?
|
| Brain Neoplasms | 5 | 2019 | 8776 | 0.160 |
Why?
|
| Intracranial Aneurysm | 2 | 2020 | 1342 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 3693 | 0.150 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2016 | 76 | 0.150 |
Why?
|
| Eating | 2 | 2014 | 1443 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2005 | 1530 | 0.150 |
Why?
|
| Intracranial Hypotension | 1 | 2015 | 33 | 0.140 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2011 | 302 | 0.140 |
Why?
|
| Brain Stem Neoplasms | 1 | 2017 | 206 | 0.140 |
Why?
|
| Atrophy | 4 | 2013 | 1509 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 709 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2020 | 771 | 0.130 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 2 | 2004 | 32 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 4677 | 0.130 |
Why?
|
| Prion Diseases | 1 | 2014 | 80 | 0.130 |
Why?
|
| Radiosurgery | 2 | 2020 | 1352 | 0.130 |
Why?
|
| Humans | 59 | 2020 | 708843 | 0.120 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2020 | 782 | 0.120 |
Why?
|
| Sodium Chloride | 1 | 2015 | 640 | 0.120 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2013 | 86 | 0.120 |
Why?
|
| Hydrocephalus | 1 | 2018 | 716 | 0.110 |
Why?
|
| Spermatozoa | 1 | 2016 | 630 | 0.110 |
Why?
|
| Cerebral Angiography | 3 | 2013 | 1384 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2011 | 249 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2005 | 1829 | 0.100 |
Why?
|
| Forecasting | 2 | 2019 | 2941 | 0.100 |
Why?
|
| Artifacts | 1 | 2019 | 1904 | 0.100 |
Why?
|
| Follicular Phase | 1 | 2011 | 153 | 0.100 |
Why?
|
| Glycemic Index | 1 | 2013 | 385 | 0.100 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2014 | 656 | 0.100 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2013 | 236 | 0.100 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 1377 | 0.100 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1287 | 0.100 |
Why?
|
| Embolism | 1 | 2013 | 388 | 0.100 |
Why?
|
| Clinical Competence | 2 | 2019 | 4615 | 0.100 |
Why?
|
| Female | 31 | 2020 | 375205 | 0.100 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2653 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1580 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 4165 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2014 | 674 | 0.090 |
Why?
|
| Middle Aged | 21 | 2020 | 213752 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 6338 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2011 | 497 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2013 | 710 | 0.090 |
Why?
|
| Protein Structure, Secondary | 2 | 2011 | 1232 | 0.080 |
Why?
|
| Brain Edema | 1 | 2012 | 616 | 0.080 |
Why?
|
| Gait | 1 | 2013 | 722 | 0.080 |
Why?
|
| Male | 27 | 2020 | 349524 | 0.080 |
Why?
|
| Pain | 1 | 2002 | 4636 | 0.080 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 14836 | 0.080 |
Why?
|
| Reward | 1 | 2013 | 843 | 0.080 |
Why?
|
| Biochemistry | 1 | 2007 | 120 | 0.080 |
Why?
|
| Leptin | 1 | 2014 | 1572 | 0.080 |
Why?
|
| Biophysics | 1 | 2007 | 394 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2019 | 5556 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 3936 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2013 | 1306 | 0.070 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2005 | 11 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2020 | 2806 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2011 | 1712 | 0.070 |
Why?
|
| Toluene | 1 | 2005 | 43 | 0.070 |
Why?
|
| Avitaminosis | 1 | 2005 | 35 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 3972 | 0.070 |
Why?
|
| Dimerization | 1 | 2007 | 909 | 0.070 |
Why?
|
| raf Kinases | 1 | 2005 | 121 | 0.070 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2004 | 27 | 0.070 |
Why?
|
| Methadone | 1 | 2007 | 285 | 0.070 |
Why?
|
| Adult | 13 | 2020 | 211041 | 0.070 |
Why?
|
| Narcotics | 1 | 2007 | 322 | 0.070 |
Why?
|
| Fasting | 1 | 2011 | 1608 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15053 | 0.070 |
Why?
|
| Epistaxis | 1 | 2005 | 109 | 0.070 |
Why?
|
| Fibrous Dysplasia, Monostotic | 1 | 2004 | 12 | 0.070 |
Why?
|
| Dura Mater | 2 | 2018 | 294 | 0.070 |
Why?
|
| Mucocele | 1 | 2004 | 51 | 0.060 |
Why?
|
| Petrous Bone | 1 | 2004 | 90 | 0.060 |
Why?
|
| Debridement | 1 | 2006 | 496 | 0.060 |
Why?
|
| Postural Balance | 1 | 2009 | 635 | 0.060 |
Why?
|
| Azacitidine | 1 | 2005 | 297 | 0.060 |
Why?
|
| Brain Abscess | 1 | 2004 | 118 | 0.060 |
Why?
|
| Empty Sella Syndrome | 1 | 2002 | 14 | 0.060 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2011 | 1080 | 0.060 |
Why?
|
| Mastoiditis | 1 | 2002 | 34 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 2926 | 0.060 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2002 | 84 | 0.060 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2004 | 184 | 0.060 |
Why?
|
| Parotid Neoplasms | 1 | 2004 | 161 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2004 | 639 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 1102 | 0.060 |
Why?
|
| Visual Perception | 1 | 2011 | 1401 | 0.060 |
Why?
|
| Radiography | 2 | 2005 | 6989 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2005 | 39038 | 0.060 |
Why?
|
| Sjogren's Syndrome | 1 | 2004 | 234 | 0.060 |
Why?
|
| Nasal Mucosa | 1 | 2005 | 369 | 0.060 |
Why?
|
| Pyrroles | 1 | 2009 | 1182 | 0.050 |
Why?
|
| Encephalocele | 1 | 2002 | 138 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1264 | 0.050 |
Why?
|
| Pharyngeal Diseases | 1 | 2002 | 139 | 0.050 |
Why?
|
| Neck Injuries | 1 | 2002 | 142 | 0.050 |
Why?
|
| Fistula | 1 | 2002 | 216 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 3418 | 0.050 |
Why?
|
| Diagnosis, Differential | 5 | 2014 | 13274 | 0.050 |
Why?
|
| Protein Binding | 3 | 2011 | 9639 | 0.050 |
Why?
|
| Bone Diseases | 1 | 2004 | 423 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1857 | 0.050 |
Why?
|
| Nasal Cavity | 1 | 2002 | 307 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2020 | 4883 | 0.050 |
Why?
|
| Injury Severity Score | 1 | 2002 | 987 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2002 | 329 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2005 | 23284 | 0.050 |
Why?
|
| Phantom Limb | 1 | 2000 | 72 | 0.050 |
Why?
|
| Gadolinium | 1 | 2004 | 910 | 0.040 |
Why?
|
| Brain Mapping | 3 | 2013 | 6545 | 0.040 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 924 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 2018 | 38 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2013 | 6255 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2006 | 1312 | 0.040 |
Why?
|
| Cysticercosis | 1 | 1997 | 20 | 0.040 |
Why?
|
| Rhinitis | 1 | 2005 | 659 | 0.040 |
Why?
|
| Craniotomy | 2 | 2020 | 727 | 0.040 |
Why?
|
| Aged | 9 | 2020 | 161488 | 0.040 |
Why?
|
| HIV Infections | 1 | 2003 | 15538 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 2060 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 1682 | 0.040 |
Why?
|
| Sinusitis | 1 | 2005 | 875 | 0.040 |
Why?
|
| Syndrome | 1 | 2002 | 3177 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2013 | 1887 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2015 | 315 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 588 | 0.030 |
Why?
|
| Sperm Motility | 1 | 2016 | 248 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 14215 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2981 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2011 | 5456 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2019 | 933 | 0.030 |
Why?
|
| Pregnancy | 3 | 2020 | 26832 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 18748 | 0.030 |
Why?
|
| Hemangioma, Cavernous | 1 | 1994 | 110 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 4044 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2020 | 2927 | 0.030 |
Why?
|
| Adolescent | 4 | 2014 | 84718 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 894 | 0.030 |
Why?
|
| Contrast Media | 2 | 2019 | 5267 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2005 | 3690 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2007 | 23950 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2019 | 1192 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 672 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2011 | 119 | 0.030 |
Why?
|
| Hunger | 1 | 2013 | 196 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2005 | 5918 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 815 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2013 | 303 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2014 | 61932 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2020 | 71483 | 0.030 |
Why?
|
| Middle Cerebral Artery | 1 | 2013 | 280 | 0.030 |
Why?
|
| Prognosis | 2 | 2020 | 28919 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2005 | 4099 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 2008 | 0.030 |
Why?
|
| Obesity | 1 | 2013 | 12031 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2011 | 350 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2016 | 1812 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 714 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2005 | 2100 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2011 | 384 | 0.020 |
Why?
|
| Food | 1 | 2014 | 708 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11126 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 13714 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1688 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 732 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 2203 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Developing Countries | 1 | 2001 | 2674 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9256 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 10085 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 58184 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 6991 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2014 | 2021 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2020 | 0.020 |
Why?
|
| Sensation Disorders | 1 | 2009 | 158 | 0.020 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2009 | 143 | 0.020 |
Why?
|
| Agar | 1 | 2005 | 50 | 0.020 |
Why?
|
| Butadienes | 1 | 2005 | 115 | 0.020 |
Why?
|
| Incidence | 1 | 2004 | 20320 | 0.020 |
Why?
|
| Methanol | 1 | 2005 | 89 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 13202 | 0.020 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2009 | 813 | 0.020 |
Why?
|
| Tomography, X-Ray | 1 | 2004 | 60 | 0.020 |
Why?
|
| Estradiol | 1 | 2011 | 1974 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 695 | 0.020 |
Why?
|
| Parotid Gland | 1 | 2004 | 164 | 0.020 |
Why?
|
| Cell Line | 2 | 2011 | 16657 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1636 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2169 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21194 | 0.010 |
Why?
|
| Flavonoids | 1 | 2005 | 421 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7487 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 576 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1126 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 16008 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 725 | 0.010 |
Why?
|
| Ovary | 1 | 2005 | 997 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9641 | 0.010 |
Why?
|
| Amputation Stumps | 1 | 2000 | 38 | 0.010 |
Why?
|
| Nitriles | 1 | 2005 | 950 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 1126 | 0.010 |
Why?
|
| Health Planning | 1 | 2001 | 242 | 0.010 |
Why?
|
| Mexico | 1 | 2001 | 673 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 2461 | 0.010 |
Why?
|
| Ethanol | 1 | 2005 | 1245 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12447 | 0.010 |
Why?
|
| Cerebral Ventriculography | 1 | 1997 | 46 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 3984 | 0.010 |
Why?
|
| Spinal Canal | 1 | 1997 | 41 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2000 | 542 | 0.010 |
Why?
|
| Mice | 3 | 2016 | 80876 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 1997 | 83 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2005 | 2401 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 55940 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 3093 | 0.010 |
Why?
|
| Equipment Design | 1 | 2005 | 3627 | 0.010 |
Why?
|
| HIV-1 | 1 | 2014 | 6757 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3879 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3968 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4353 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2936 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 6293 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 539 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2680 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 3563 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2005 | 3006 | 0.010 |
Why?
|
| Leg | 1 | 2000 | 1160 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2005 | 4299 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 4317 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 69553 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 7090 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3892 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2001 | 1435 | 0.010 |
Why?
|
| Animals | 3 | 2016 | 170486 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 23020 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 5525 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 8877 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 5405 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1994 | 383 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2000 | 1426 | 0.010 |
Why?
|
| Child | 1 | 2018 | 73636 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 13314 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 50597 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 25094 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16959 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 34261 | 0.000 |
Why?
|
| Time Factors | 1 | 2003 | 41038 | 0.000 |
Why?
|
| Mutation | 1 | 2005 | 29262 | 0.000 |
Why?
|